We use cookies to ensure that we give you the best experience on our website and to analyse site usage. If you click "ACCEPT” to use this site we will assume that you are happy with it.
By clicking “ACCEPT” you have confirmed that you have read, understood and agreed to the legal terms and conditions of this website. You also: (i) agree that such information will apply to any subsequent access to this website by you, and that all such subsequent access will be subject to the disclaimers, risk warnings and other information set out herein; and (ii) warrant that no other person will access this website from the same computer and logon as you are currently using.
Alek Safarian shares his opinions on the current funding environment for biotech, and introduces ALSA Ventures and its investment philosophy.
May 1, 2024
ALSA Ventures CEO Alek Safarian recently sat down with BiotechTV to share his views on the current biotech venture capital funding environment in UK and Europe, and where the industry is heading.